6.19
Sight Sciences Inc 주식(SGHT)의 최신 뉴스
Sight Sciences, Inc. (NASDAQ:SGHT) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
MarketBeat
Sight Sciences, Inc. (NASDAQ:SGHT) Receives Consensus Rating of “Hold” from Analysts - Defense World
Defense World
Sight Sciences, Inc. (SGHT) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Canada Shine On
Yahoo Canada Shine On
Investing in Sight Sciences Inc (SGHT) Is Getting More Attractive – Knox Daily - Knox Daily
Knox Daily
SGHT underperforms with a -0.78 decrease in share price – US Post News - US Post News
US Post News
Analyzing Sight Sciences (NASDAQ:SGHT) & Tactile Systems Technology (NASDAQ:TCMD) - Defense World
Defense World
How To Trade (SGHT) - Stock Traders Daily
Stock Traders Daily
One Sight Sciences Insider Raised Stake By 34% In Previous Year - Yahoo Finance
Yahoo Finance
Sight Sciences Releases Its First Sustainability Report - Vision Monday
Vision Monday
Sight Sciences (NASDAQ:SGHT) adds US$55m to market cap in the past 7 days, though investors from a year ago are ... - Yahoo Lifestyle UK
Yahoo Lifestyle UK
Sight Sciences Releases Its First Sustainability Report - Vision Monday
Vision Monday
Sight Sciences Announces the Release of its First Sustainability Report - GlobeNewswire
GlobeNewswire
Sight Sciences Announces the Release of its First Sustainability Report - GlobeNewswire
GlobeNewswire
Sight Sciences Announces the Release of its First Sustainability Report - Yahoo Finance
Yahoo Finance
The five (and more) human senses - Livescience.com
Livescience.com
Strength Seen in Sight Sciences, Inc. (SGHT): Can Its 5.6% Jump Turn into More Strength? - Yahoo Singapore News
Yahoo Singapore News
RTW Investments LP Buys New Position in Sight Sciences, Inc. (NASDAQ:SGHT) - MarketBeat
MarketBeat
RTW Investments LP Buys New Position in Sight Sciences, Inc. (NASDAQ:SGHT) - MarketBeat
MarketBeat
Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Tops Revenue Estimates - Yahoo News Malaysia
Yahoo News Malaysia
Stereotaxis Inc. (STXS) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Canada Shine On
Yahoo Canada Shine On
Sight Sciences, Inc. (NASDAQ:SGHT) Shares Purchased by UBS Group AG - MarketBeat
MarketBeat
UBS Group AG Has $14.94 Million Stock Holdings in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World
Defense World
Strength Seen in Sight Sciences, Inc. (SGHT): Can Its 5.6% Jump Turn into More Strength? - Yahoo Singapore News
Yahoo Singapore News
Sight Sciences, Inc. (NASDAQ:SGHT) Receives $4.70 Average Target Price from Analysts - MarketBeat
MarketBeat
After losing 34% in the past year, Sight Sciences, Inc. (NASDAQ:SGHT) institutional owners must be relieved by the recent gain - Simply Wall St
Simply Wall St
Sight Sciences, Inc. (NASDAQ:SGHT) Receives Average Rating of “Hold” from Analysts - Defense World
Defense World
After losing 34% in the past year, Sight Sciences, Inc. (NASDAQ:SGHT) institutional owners must be relieved by the recent gain - Simply Wall St
Simply Wall St
Sight Sciences reports positive TearCare results in dry eye study By Investing.com - Investing.com Australia
Investing.com Australia
Sight Sciences' TearCare leads to long term improvement in dry eye disease - Clinical Trials Arena
Clinical Trials Arena
Sight Sciences' TearCare leads to long term improvement in dry eye disease - Medical Device Network
Medical Device Network
Sight Sciences' TearCare leads to long term improvement in dry eye disease - Medical Device Network
Medical Device Network
Sight Sciences reports positive TearCare results in dry eye study By Investing.com - Investing.com UK
Investing.com UK
Sight Sciences Announces the Publication of Twelve-Month Results of the SAHARA RCT Demonstrating Improved ... - GlobeNewswire
GlobeNewswire
Sight Sciences Announces the Publication of Twelve-Month Results of the SAHARA RCT Demonstrating Improved ... - Yahoo Finance
Yahoo Finance
Sight Sciences reports consistent glaucoma treatment efficacy By Investing.com - Investing.com
Investing.com
Sight Sciences reports consistent glaucoma treatment efficacy By Investing.com - Investing.com
Investing.com
Sight Sciences reports consistent glaucoma treatment efficacy By Investing.com - Investing.com UK
Investing.com UK
Sight Sciences Announces Publication of a New Analysis from The ROMEO Study Showing Meaningful Pressure and ... - GlobeNewswire
GlobeNewswire
Sight Sciences Announces Publication of a New Analysis from The ROMEO Study Showing Meaningful Pressure and ... - Yahoo Finance
Yahoo Finance
Sight Sciences Announces Publication of a New Analysis from The ROMEO Study Showing Meaningful Pressure and ... - GlobeNewswire
GlobeNewswire
Sight Sciences reports consistent glaucoma treatment efficacy By Investing.com - Investing.com
Investing.com
When (SGHT) Moves Investors should Listen - Stock Traders Daily
Stock Traders Daily
Panagora Asset Management Inc. Buys 39333 Shares of Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World
Defense World
Alison Bauerlein Sells 13066 Shares of Sight Sciences, Inc. (NASDAQ:SGHT) Stock - Defense World
Defense World
Sight Sciences CFO sells $70,869 in company stock By Investing.com - Investing.com
Investing.com
Sight Sciences CFO sells $70869 in company stock - Investing.com India
Investing.com India
They received retinal implants to restore their vision. Then the company turned its back on them. - upworthyscience.com
upworthyscience.com
Sight Sciences, Inc. (NASDAQ:SGHT) Shares Purchased by Jackson Square Partners LLC - MarketBeat
MarketBeat
How the (SGHT) price action is used to our Advantage - Stock Traders Daily
Stock Traders Daily
Sight Sciences (SGHT) Stock Forecast and Price Target 2024 - MarketBeat
MarketBeat
자본화:
|
볼륨(24시간):